Development and validation of a novel risk stratification signature derived from migrasome and tumor microenvironment-related genes for molecular subtyping and improving clinical outcomes in head and neck squamous cell carcinoma
This study presents an innovative gene signature associated with mtmRGs, which may be utilized both for predicting survival and directing personalized chemotherapy and immunotherapy regiments for patients with HNSCC.
Authors
- Chuchu Zhou (ORCID: https://orcid.org/0009-0008-8339-5146)
- Feng Lu (ORCID: https://orcid.org/0000-0003-4868-7908)
- Zhiyi Xue (ORCID: https://orcid.org/0000-0002-1357-202X)
- Min Zhang (ORCID: https://orcid.org/0000-0001-8083-5603)
- Jianjun Wang (ORCID: https://orcid.org/0000-0002-1876-5103)
- Huifang Chai
- Ling Qiao (ORCID: https://orcid.org/0000-0001-7633-4398)
Institutions
- Henan University (CN)
- Henan University Huaihe Hospital and Huaihe Clinical Institute (CN)
- Henan Medical University (CN)
Publication Details
- Journal
- Annals of Medicine
- Published
- 2025-09-09
- DOI
- https://doi.org/10.1080/07853890.2025.2558121
- Citations
- 1
- Primary Topic
- Peptidase Inhibition and Analysis
- Type
- article
- Field-Weighted Citation Impact
- 1.05